Medacta Group saw the highest growth of 0.49% in patent filings in May and 1.24% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.62%. GlobalData’s DataBook provides a comprehensive analysis of Medacta Group‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Medacta Group has been focused on protecting inventions in European Patent Office(EPO) with six publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 33% filings and 29% grants. The European Patent Office(EPO), United States(US), Australia(AU), and Spain(ES) patent Office are among the top ten patent offices where Medacta Group is filings its patents. Among the top granted patent authorities, Medacta Group has 29% of its grants in European Patent Office(EPO), 29% in United States(US) and 14% in Australia(AU).
Johnson & Johnson and Stryker could be the strongest competitors for Medacta Group
In terms of grant share, Medacta Group stands in third position among its competitors. Johnson & Johnson and Stryker secured the top positions according to recent patent publication data.
Patents related to healthtech and cell & gene therapy lead Medacta Group's portfolio
Medacta Group has the highest number of patents in healthtech followed by, cell & gene therapy. For healthtech, nearly 100% of patents were filed and 50% of patents were granted in Q2 2024.
Orthopedic devices related patents lead Medacta Group portfolio followed by general surgery devices, and spinal fusion
Medacta Group has highest number of patents in orthopedic devices followed by general surgery devices, spinal fusion, image management. For orthopedic devices, nearly 75% of patents were filed and 73% of patents were granted in Q2 2024.
For comprehensive analysis of Medacta Group's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
